By Frank Prenesti
Date: Thursday 26 Feb 2026
(Sharecast News) - Shares in Gerresheimer slumped on Thursday after the medical products maker said a day earlier that Germany's financial regulator BaFin was expanding its probe into the company's financial statements.
The new investigation comes amid ongoing internal reviews of its accounting practices. Gerresheimer also delayed publication of its 2024...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news